Venock

Venock is a private medical technology company developing a percutaneous vascular closure device for very large bore access sites created during transcatheter cardiovascular procedures. The company is initially focused on automated closure of femoral venous punctures, where current practice often relies on prolonged manual compression, immobilization, and overnight monitoring. Venock has also stated that its core closure principle can be extended to arterial access sites, positioning the technology as a potential universal large-bore vascular closure solution. The device is designed to shorten closure time, improve patient mobilization and discharge, and reduce procedure-related resource use in interventional cardiology settings. Venock is headquartered in New York City and operates through Venock Medical GmbH in Germany.